Literature DB >> 8091264

Hepatotoxicity from propylthiouracil.

S A Westphal1.   

Abstract

Propylthiouracil is a drug used commonly to treat hyperthyroidism. Among its side effects, hepatotoxicity is one of the rarest but one of the most serious. This complication may be due to an immune mechanism. However, particular risk factors associated with the development of hepatotoxicity are not known, and its occurrence is unpredictable. I report a case of acute hepatitis developing during propylthiouracil therapy for Graves' disease and review the literature related to this problem.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091264     DOI: 10.1097/00007611-199409000-00018

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Propylthiouracil-induced hepatotoxicity.

Authors:  J T Hardee; A L Barnett; A Thannoun; B Eghtesad; D Wheeler; M M Jamal
Journal:  West J Med       Date:  1996-09

2.  Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use.

Authors:  Scott A Rivkees; Donald R Mattison
Journal:  Int J Pediatr Endocrinol       Date:  2009-04-21

3.  Carbimazole-induced cholestatic hepatitis in Graves' disease.

Authors:  Sunil K Kota; Lalit K Meher; Siva K Kota; Sruti Jammula; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2013-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.